Feedback / Questions
pegtarazimod (RLS-0071) - ReAlta
https://www.businesswire.com/news/home/20240328968015/en/ReAlta-Life-Sciences-Announces-New-Research-Collaboration-with-the-National-Institute-of-Allergy-and-Infectious-Diseases-to-Evaluate-RLS-0071-as-a-Medical-Countermeasure-for-Acute-Radiation-Syndrome
Mar 28, 2024
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next